Pharmacy Referral Payments and Copay Waivers
A local pharmacy owner asks agent Marcus to attend a senior fair and steer beneficiaries to the pharmacy’s “Medicare help desk.” The owner offers Marcus $40 for each beneficiary who lists Marcus’s name on an enrollment form and says the pharmacy will routinely waive the $30 copay for a preferred Medicare Advantage-PD plan’s tier 3 drug. Separately, a plan marketing representative tells Marcus that the plan will pay a $100 “referral bonus” for every dual-eligible beneficiary who enrolls in its D-SNP, even if Marcus is not the agent of record. Marcus is licensed and appointed with the plan. He has not yet accepted either arrangement and asks whether he can participate if he discloses the payments to beneficiaries.
1. Identify the fraud, waste, and abuse concerns in each arrangement. Distinguish the pharmacy payment, the copay waiver, and the plan referral bonus.
Read the worked answer
The $40 per beneficiary is classic remuneration for referral of federal health care program business, raising Anti-Kickback Statute and beneficiary-inducement risk. The routine $30 copay waiver is also risky: a waiver can be an inducement, and repeated waivers can violate the Anti-Kickback Statute and Civil Monetary Penalties unless a specific exception applies, such as a documented financial-need or CMS-approved reward program. Disclosure to the beneficiary does not cure a kickback. The $100 D-SNP referral bonus is also problematic: agents must be paid under CMS-compliant compensation rules and appointed or contracted arrangements; paying a bonus for enrollments where Marcus is not the agent of record looks like payment for referrals, not legitimate services. All three arrangements should be treated as red flags, not merely marketing expenses.
2. What should Marcus do next, and what should he document?
Read the worked answer
Marcus should decline both offers in writing, not accept or route any beneficiary, and not use the pharmacy’s help desk as a lead source. He should report the offers to the plan’s compliance department and, if appropriate, the OIG hotline; he should preserve emails, texts, and notes with dates, names, amounts, and the beneficiaries involved. If he already received any payment, he should not keep it and should ask compliance how to return or disclose it. He should also avoid retaliating or discussing the report with the pharmacy. His license and appointment depend on following CMS marketing and compensation rules, and a disclosure to consumers would not make an illegal arrangement lawful.
3. Beneficiary Mrs. Lee tells Marcus she was offered a $50 grocery card to attend the pharmacy’s help desk and enroll. How should Marcus respond, and does it matter that she has not enrolled?
Read the worked answer
The offer itself is a problem. A $50 grocery card is above the nominal gift limit of $15 per item and $75 per year, and it is tied to attending a marketing event and enrolling, so it looks like a beneficiary inducement under the Civil Monetary Penalties rules. It does not matter that Mrs. Lee has not enrolled yet; the offer can be improper, and if she enrolls because of it, the enrollment may be tainted. Marcus should tell her not to accept the card, explain that plan marketing cannot use cash or gifts to influence enrollment, document what she was told, and report the pharmacy to the plan and compliance. He should not enroll her through that event.